Tiantan Building Large Vaccine Facility in BDA

Beijing Tiantan Biological Products, a biopharmaceutical company, is developing a 2.7 billion RMB ($400 million) biological vaccine production facility in the Beijing Economic-Technological Development Area (BDA). The company makes vaccines, blood-related products and diagnostic devices. One of its major product lines is hepatitis B vaccines. More details... Stock Symbol: (SHSE: 600161)